ANIK
Anika Therapeutics, Inc.Company with tickers: ANIK
Market Cap
$200.91M
Shares Outstanding
13,305,624
CIK
898437
CUSIP
035255108
13F Activity (30d)
1 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$15,000,000
as of 2025-11-06
Remaining Authorization
$12,000,000
as of 2020-01-14
· not restated in filings since 2022-03-11
Program Utilization
20.0%
$3,000,000 used of $15,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $8,690,000 | 10-Q, filed 2026-04-30 |
| 2025-12-31 | $9,485,000 | 10-K, filed 2026-03-03 |
| 2024-12-31 | $10,914,000 | 10-K, filed 2026-03-03 |
| 2023-12-31 | $5,000,000 | 10-K, filed 2026-03-03 |
| 2022-12-31 | $0 | 10-K, filed 2025-03-17 |
| 2021-12-31 | $0 | 10-K, filed 2024-03-15 |
| 2020-12-31 | $0 | 10-K, filed 2022-03-11 |
| 2019-12-31 | $30,000,000 | 10-K, filed 2022-03-11 |
| 2018-12-31 | $30,000,000 | 10-K/A, filed 2021-04-26 |
| 2016-12-31 | $25,000,000 | 10-K, filed 2019-02-27 |